HIV BG505.v5.2 (N289/N241) SOSIP Env in Complex with V5, gp120-Interface, and Anti-Immune Complex pAbs from Rh.33203

HIV BG505.v5.2 (N289/N241) SOSIP Env in Complex with V5, gp120-Interface, and Anti-Immune Complex pAbs from Rh.33203 Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... Authors: Brown, S, Antansijevic, A, Ward, A.B. Deposit date: 2024-03-08 Release date: 2025-01-29 Last modified: 2025-05-14 Method: ELECTRON MICROSCOPY (4.6 Å) Cite: Anti-immune complex antibodies are elicited during repeated immunization with HIV Env immunogens. Sci Immunol, 10, 2025

HIV BG505.v5.2 (N289/N241) SOSIP包膜蛋白（Env）与V5、gp120界面及源自Rh.33203的抗免疫复合物多克隆抗体形成的复合物结构。描述符：2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖，2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖-(1→3)-2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖-(1→4)-2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖，2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖-(1→4)-2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖，…… 作者：Brown, S、Antansijevic, A、Ward, A.B.。沉积日期：2024-03-08，发布日期：2025-01-29，最后修改日期：2025-05-14。实验方法：电子显微镜（分辨率4.6 Å）。引用文献：采用HIV包膜蛋白免疫原反复免疫可诱导产生抗免疫复合物抗体，发表于《Science Immunology》，第10卷，2025年